969 |
Timing of Angiography (Early Invasive vs. Conservative) for High-Risk ACS; (TIMACS, ISAR-COOL, and ABOARD) |
Christian M. Spaulding |
May. 04. 10 |
968 |
New Thienopyridine Use in ACS and PCI (TRITON-TIMI 38 and Several Subgroup Analyses, PLATO and Several Subgroup Analyses, and CHAMPION Trials) |
David Joel Cohen |
May. 04. 10 |
967 |
Parenteral Anticoagulants Use in ACS (HORIZONS-AMI, and SEPIA-ACS Trial) |
Roxana Mehran |
May. 04. 10 |
966 |
Clopidogrel Use in ACS and PCI (CURRENT-OASIS 7, Genetic Resistance Studies, GRAVITAS, CLARITY-TIMI 28, and PPI & DAT for ACS; VA Registry, PRINCIPLE, TRITON-TIMI 38, COGENT, and FAMOUS) |
Matthew Price |
May. 04. 10 |
965 |
Glycoprotein IIb/IIIa Inhibitors at Primary PCI in STEMI (BRAVE-3, ON-TIME2, HORIZONS-AMI, MULTISTRATEGY, and FINESSE) |
Adnan Kastrati |
May. 04. 10 |
964 |
Surgeon's View of Hybrid Procedures |
Tae Jin Yun |
May. 04. 10 |
963 |
Hybrid Procedure in HLHS |
Teiji Akagi |
May. 04. 10 |
962 |
New Directions- Structural Heart Disease Intervention |
Horst Sievert |
May. 04. 10 |
961 |
Update on Percutaneous PFO Closure |
Horst Sievert |
May. 04. 10 |
960 |
Percutaneous Aortic Valve Implantation- Initial Experience in Asia |
Paul Toon Lim Chiam |
May. 04. 10 |